US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 37.980
  • +0.030+0.08%
Close Jul 19 16:00 ET
4.61BMarket Cap-11072P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
290.37%22.06M
2,519.90%16.32M
Operating revenue
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
290.37%22.06M
2,519.90%16.32M
Cost of revenue
158.79%20.21M
938.15%58.51M
580.75%19.91M
1,522.74%22.41M
10,118.29%8.38M
526.22%7.81M
8.38%5.64M
-42.09%2.93M
826.85%1.38M
82K
Gross profit
310.71%152.12M
384.45%338.08M
540.72%126.47M
325.58%87.99M
433.19%86.59M
181.99%37.04M
13.73%69.79M
-64.27%19.74M
275.84%20.68M
2,506.74%16.24M
Operating expense
0.98%214.21M
28.72%855.2M
14.80%210.98M
29.64%225.07M
25.58%207.03M
49.24%212.12M
11.17%664.4M
27.07%183.79M
30.05%173.61M
-15.42%164.86M
Selling and administrative expenses
26.85%129.51M
80.69%500.82M
67.96%141.7M
85.76%145.65M
76.21%111.37M
99.45%102.09M
56.79%277.16M
103.48%84.37M
71.33%78.41M
29.07%63.2M
-General and administrative expense
----
80.69%500.82M
67.96%141.7M
85.76%145.65M
76.21%111.37M
----
56.79%277.16M
103.48%84.37M
71.33%78.41M
29.07%63.2M
Research and development costs
-23.02%84.7M
-8.48%354.39M
-30.32%69.28M
-16.58%79.42M
-5.90%95.66M
20.98%110.03M
-7.99%387.24M
-3.64%99.42M
8.52%95.21M
-30.34%101.66M
Operating profit
64.54%-62.09M
13.03%-517.12M
48.48%-84.52M
10.37%-137.08M
18.96%-120.44M
-35.73%-175.08M
-10.88%-594.61M
-83.50%-164.05M
-19.49%-152.94M
23.50%-148.62M
Net non-operating interest income expense
-71.54%-3.66M
63.53%-8.65M
9.77%-2.85M
54.44%-2.32M
80.92%-1.34M
74.69%-2.14M
-84.92%-23.71M
-6.11%-3.16M
-138.26%-5.09M
-91.54%-7.02M
Non-operating interest income
-38.75%3.3M
134.83%20.93M
-0.59%4.55M
77.61%4.99M
319.13%6M
5,403.06%5.39M
2,032.54%8.91M
12,264.86%4.58M
1,850.69%2.81M
1,276.92%1.43M
Non-operating interest expense
-7.46%6.97M
-9.33%29.58M
-4.34%7.4M
-7.50%7.31M
-13.10%7.34M
-11.82%7.53M
146.40%32.63M
156.39%7.74M
246.32%7.9M
124.26%8.45M
Other net income (expense)
-80.14%-499K
97.81%-727K
189.02%219K
98.16%-603K
-142.28%-63K
4.15%-277K
83.15%-33.18M
99.55%-246K
49.89%-32.79M
100.70%149K
Special income (charges)
----
--0
--0
--0
----
----
67.30%-32.89M
--0
46.17%-32.89M
----
-Less:Other special charges
----
----
----
----
----
----
-67.30%32.89M
--0
-46.17%32.89M
----
Other non- operating income (expenses)
-80.14%-499K
-152.43%-727K
189.02%219K
-709.09%-603K
-142.28%-63K
4.15%-277K
-121.15%-288K
-6,050.00%-246K
184.62%99K
344.26%149K
Income before tax
62.67%-66.25M
19.19%-526.5M
47.96%-87.15M
26.63%-140M
21.64%-121.84M
-28.88%-177.5M
12.67%-651.5M
-13.47%-167.46M
2.43%-190.82M
29.06%-155.49M
Income tax
-39.72%170K
218.68%2.13M
196.74%1.42M
-47.76%233K
-60.08%194K
-76.66%282K
90.06%669K
-517.90%-1.47M
446K
486K
Net income
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
Net income continuous Operations
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
Minority interest income
Net income attributable to the parent company
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
28.84%-155.98M
Basic earnings per share
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
23.25%-1.75
46.32%-1.46
Diluted earnings per share
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
23.25%-1.75
46.32%-1.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M290.37%22.06M2,519.90%16.32M
Operating revenue 284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M290.37%22.06M2,519.90%16.32M
Cost of revenue 158.79%20.21M938.15%58.51M580.75%19.91M1,522.74%22.41M10,118.29%8.38M526.22%7.81M8.38%5.64M-42.09%2.93M826.85%1.38M82K
Gross profit 310.71%152.12M384.45%338.08M540.72%126.47M325.58%87.99M433.19%86.59M181.99%37.04M13.73%69.79M-64.27%19.74M275.84%20.68M2,506.74%16.24M
Operating expense 0.98%214.21M28.72%855.2M14.80%210.98M29.64%225.07M25.58%207.03M49.24%212.12M11.17%664.4M27.07%183.79M30.05%173.61M-15.42%164.86M
Selling and administrative expenses 26.85%129.51M80.69%500.82M67.96%141.7M85.76%145.65M76.21%111.37M99.45%102.09M56.79%277.16M103.48%84.37M71.33%78.41M29.07%63.2M
-General and administrative expense ----80.69%500.82M67.96%141.7M85.76%145.65M76.21%111.37M----56.79%277.16M103.48%84.37M71.33%78.41M29.07%63.2M
Research and development costs -23.02%84.7M-8.48%354.39M-30.32%69.28M-16.58%79.42M-5.90%95.66M20.98%110.03M-7.99%387.24M-3.64%99.42M8.52%95.21M-30.34%101.66M
Operating profit 64.54%-62.09M13.03%-517.12M48.48%-84.52M10.37%-137.08M18.96%-120.44M-35.73%-175.08M-10.88%-594.61M-83.50%-164.05M-19.49%-152.94M23.50%-148.62M
Net non-operating interest income expense -71.54%-3.66M63.53%-8.65M9.77%-2.85M54.44%-2.32M80.92%-1.34M74.69%-2.14M-84.92%-23.71M-6.11%-3.16M-138.26%-5.09M-91.54%-7.02M
Non-operating interest income -38.75%3.3M134.83%20.93M-0.59%4.55M77.61%4.99M319.13%6M5,403.06%5.39M2,032.54%8.91M12,264.86%4.58M1,850.69%2.81M1,276.92%1.43M
Non-operating interest expense -7.46%6.97M-9.33%29.58M-4.34%7.4M-7.50%7.31M-13.10%7.34M-11.82%7.53M146.40%32.63M156.39%7.74M246.32%7.9M124.26%8.45M
Other net income (expense) -80.14%-499K97.81%-727K189.02%219K98.16%-603K-142.28%-63K4.15%-277K83.15%-33.18M99.55%-246K49.89%-32.79M100.70%149K
Special income (charges) ------0--0--0--------67.30%-32.89M--046.17%-32.89M----
-Less:Other special charges -------------------------67.30%32.89M--0-46.17%32.89M----
Other non- operating income (expenses) -80.14%-499K-152.43%-727K189.02%219K-709.09%-603K-142.28%-63K4.15%-277K-121.15%-288K-6,050.00%-246K184.62%99K344.26%149K
Income before tax 62.67%-66.25M19.19%-526.5M47.96%-87.15M26.63%-140M21.64%-121.84M-28.88%-177.5M12.67%-651.5M-13.47%-167.46M2.43%-190.82M29.06%-155.49M
Income tax -39.72%170K218.68%2.13M196.74%1.42M-47.76%233K-60.08%194K-76.66%282K90.06%669K-517.90%-1.47M446K486K
Net income 62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M
Net income continuous Operations 62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M
Minority interest income
Net income attributable to the parent company 62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M28.84%-155.98M
Basic earnings per share 65.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.523.25%-1.7546.32%-1.46
Diluted earnings per share 65.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.523.25%-1.7546.32%-1.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.33%